Molecular Partners AG (MOLN)
4.43
+0.20
(+4.73%)
USD |
NASDAQ |
Dec 29, 16:00
Molecular Partners Research and Development Expense (Quarterly): 10.41M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 505.41M |
| AC Immune SA | 16.33M |
| CRISPR Therapeutics AG | 54.50M |
| Addex Therapeutics Ltd. | 0.2853M |
| NewCelX Ltd. | -- |